{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T18:27:43Z","timestamp":1747160863217,"version":"3.40.5"},"reference-count":33,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The French Journal of Urology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.fjurol.2024.102675","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T21:01:22Z","timestamp":1720040482000},"page":"102675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Incidence, initial management and survival of high-risk non-muscle invasive bladder cancer in Northern France"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4410-9572","authenticated-orcid":false,"given":"Fabien","family":"Saint","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Pasquier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnauld","family":"Villers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan","family":"Massa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Colin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Vankemmel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Louis","family":"Bonnal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandrine D.","family":"Plouvier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fjurol.2024.102675_bib0170","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.fjurol.2024.102675_bib0175","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1080\/00365590600744238","article-title":"Analysis of clinical characteristics, management and survival of patients with Ta, T1 bladder tumours in Sweden between 1997 and 2001","volume":"40","author":"G\u00e5rdmark","year":"2006","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.fjurol.2024.102675_bib0180","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.eururo.2008.04.051","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder","volume":"54","author":"Babjuk","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2024.102675_bib0185","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1470-2045(13)70546-1","article-title":"Cancer survival in Europe 1999\u20132007 by country and age: results of EUROCARE-5- a population-based study","volume":"15","author":"De Angelis","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.fjurol.2024.102675_bib0190","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/cncr.28397","article-title":"Trends in stage-specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006","volume":"120","author":"Nielsen","year":"2014","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.fjurol.2024.102675_bib0195","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.respe.2019.04.053","article-title":"Completeness of a newly implemented general cancer registry in northern France: application of a three-source capture-recapture method","volume":"67","author":"Plouvier","year":"2019","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.fjurol.2024.102675_bib0200","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"issue":"Suppl. 4","key":"10.1016\/j.fjurol.2024.102675_bib0205","doi-asserted-by":"crossref","first-page":"S255","DOI":"10.1016\/S1166-7087(10)70043-9","article-title":"Recommendations Onco-Urology 2010: urothelial tumors","volume":"20","author":"Pfister","year":"2010","journal-title":"Prog Urol"},{"key":"10.1016\/j.fjurol.2024.102675_bib0210","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.fjurol.2024.102675_bib0215","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1541-0420.2011.01640.x","article-title":"On estimation in relative survival","volume":"68","author":"Pohar Perme","year":"2012","journal-title":"Biometrics"},{"key":"10.1016\/j.fjurol.2024.102675_bib0220","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/003655900750016698","article-title":"Prospective registration of all patients in a geographical region with newly diagnosed bladder carcinomas during a two-year period","volume":"34","author":"Holm\u00e4ng","year":"2000","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.fjurol.2024.102675_bib0225","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0302-2838(02)00496-7","article-title":"Gender-related differences in clinical and pathological characteristics and therapy of bladder cancer","volume":"43","author":"Puente","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2024.102675_bib0230","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3109\/21681805.2015.1085089","article-title":"Swedish National Registry of Urinary Bladder Cancer: no difference in relative survival over time despite more aggressive treatment","volume":"50","author":"Jahnson","year":"2016","journal-title":"Scand J Urol"},{"key":"10.1016\/j.fjurol.2024.102675_bib0235","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/bjc.1993.147","article-title":"The clinical epidemiology of superficial bladder cancer. Dutch South-East Cooperative Urological Group","volume":"67","author":"Kiemeney","year":"1993","journal-title":"Br J Cancer"},{"key":"10.1016\/j.fjurol.2024.102675_bib0240","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.respe.2013.11.073","article-title":"Cancer incidence and mortality in France over the 1980\u20132012 period: solid tumors","volume":"62","author":"Binder-Foucard","year":"2014","journal-title":"Rev Epidemiol Sante Publique"},{"issue":"5","key":"10.1016\/j.fjurol.2024.102675_bib0245","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.juro.2009.07.016","article-title":"Predicting non-muscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model","volume":"182","author":"Fernandez-Gomez","year":"2009","journal-title":"J Urol"},{"issue":"12S","key":"10.1016\/j.fjurol.2024.102675_bib0250","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/S1166-7087(20)30751-X","article-title":"French ccAFU guidelines\u00a0\u2013\u00a0update 2020\u20132022: bladder cancer","volume":"30","author":"Roupr\u00eat","year":"2020","journal-title":"Prog Urol"},{"issue":"5","key":"10.1016\/j.fjurol.2024.102675_bib0255","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.purol.2022.01.004","article-title":"Guidelines from the cancer committee of the French Association of Urology (CC-AFU) for adequate intravesical instillations of Mitomycin C, Epirubicin, and BCG for non-muscle invasive bladder cancer","volume":"32","author":"Leon","year":"2022","journal-title":"Prog Urol"},{"key":"10.1016\/j.fjurol.2024.102675_bib0260","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.eururo.2010.03.007","article-title":"Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial","volume":"58","author":"Divrik","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2024.102675_bib0265","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/01.ju.0000070437.14275.e0","article-title":"Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study","volume":"170","author":"Grimm","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.fjurol.2024.102675_bib0270","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/bju.13354","article-title":"The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade\/Grade 3 bladder cancer treated with bacille Calmette-Gu\u00e9rin","volume":"118","author":"Gontero","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2024.102675_bib0275","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nrurol.2016.165","article-title":"Bladder cancer: low adherence to guidelines in non-muscle-invasive disease","volume":"13","author":"van Rhijn","year":"2016","journal-title":"Nat Rev Urol"},{"issue":"4","key":"10.1016\/j.fjurol.2024.102675_bib0280","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1080\/21681805.2021.1917652","article-title":"The use of reTURB in T1 bladder cancer: a Norwegian population-based study","volume":"55","author":"Blindheim","year":"2021","journal-title":"Scand J Urol"},{"key":"10.1016\/j.fjurol.2024.102675_bib0285","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.eururo.2018.02.014","article-title":"Repeat transurethral resection in non-muscle-invasive bladder cancer: a systematic review","volume":"73","author":"Cumberbatch","year":"2018","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.fjurol.2024.102675_bib0290","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-5347(05)67973-6","article-title":"Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations","volume":"163","author":"Lebret","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.fjurol.2024.102675_bib0295","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.1002\/cncr.26198","article-title":"Compliance with guidelines for patients with bladder cancer: variation in the delivery of care","volume":"117","author":"Chamie","year":"2011","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.fjurol.2024.102675_bib0300","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/bju.15413","article-title":"Time interval from transurethral resection of bladder tumour to bacille Calmette-Gu\u00e9rin induction does not impact therapeutic response","volume":"128","author":"Hensley","year":"2021","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2024.102675_bib0305","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.eururo.2014.11.031","article-title":"Therapeutic options in high-risk non-muscle-invasive bladder cancer during the current worldwide shortage of bacille Calmette-Gu\u00e9rin","volume":"67","author":"Mostafid","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.fjurol.2024.102675_bib0310","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/0284186X.2020.1723164","article-title":"Impact of age on bladder cancer management practices: a general population study","volume":"59","author":"Plouvier","year":"2020","journal-title":"Acta Oncol"},{"key":"10.1016\/j.fjurol.2024.102675_bib0315","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/21681805.2017.1298156","article-title":"Intravesical instillations and cancer-specific survival in patients with primary carcinoma in situ of the urinary bladder","volume":"51","author":"Jancke","year":"2017","journal-title":"Scand J Urol"},{"key":"10.1016\/j.fjurol.2024.102675_bib0320","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/bju.13474","volume":"118","author":"Oddens","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.fjurol.2024.102675_bib0325","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1002\/cncr.25007","article-title":"Patterns of care for early stage bladder cancer","volume":"116","author":"Strope","year":"2010","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.fjurol.2024.102675_bib0330","first-page":"2067","article-title":"Pronostic impact of non-adherence to follow-up cystoscopy in NMIBC","volume":"37","author":"Datovo","year":"2019","journal-title":"WJU"}],"container-title":["The French Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950393024001323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950393024001323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T02:21:07Z","timestamp":1726453267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950393024001323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2950393024001323"],"URL":"https:\/\/doi.org\/10.1016\/j.fjurol.2024.102675","relation":{},"ISSN":["2950-3930"],"issn-type":[{"type":"print","value":"2950-3930"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence, initial management and survival of high-risk non-muscle invasive bladder cancer in Northern France","name":"articletitle","label":"Article Title"},{"value":"The French Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fjurol.2024.102675","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102675"}}